52 results  1 of 3 

1 Cost-effective BRCA Testing in Advanced Ovarian Cancer
Myungshin Kim
Ann Lab Med.2023;43(1):3-4.   Published online 2022 September 1     DOI: http://dx.doi.org/10.3343/alm.2023.43.1.3
      
2 Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
Jaehyeok Jang, Yoonjung Kim, Jae-Hoon Kim, Sun-Mi Cho, Kyung-A Lee
Ann Lab Med.2023;43(1):73-81.   Published online 2022 September 1     DOI: http://dx.doi.org/10.3343/alm.2023.43.1.73
      
3 Founder BRCA1 mutations in Nepalese population
Anurag Mehta, Himanshi Diwan, Garima Gupta, Shrinidhi Nathany, Shalini Agnihotri, Surender Dhanda
J Pathol Transl Med.2022;56(4):212-216.   Published online 2022 June 15     DOI: http://dx.doi.org/10.4132/jptm.2022.05.02
      
4 Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation
Ju Won Kim, Hyo Eun Kang, Jimi Choi, Seung Gyu Yun, Seung Pil Jung, Soo Yeon Bae, Ji Young You, Yoon-Ji Choi, Yeul Hong Kim, Kyong Hwa Park
Cancer Res Treat.2023;55(1):155-166.   Published online 2022 June 8     DOI: http://dx.doi.org/10.4143/crt.2021.1567
      
5 Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation–Negative Breast Cancer
Ji Soo Park, Saeam Shin, Yoon Jung Lee, Seung-Tae Lee, Eun Ji Nam, Jung Woo Han, Sun Hwa Lee, Tae Il Kim, Hyung Seok Park
Cancer Res Treat.2022;54(4):1099-1110.   Published online 2021 November 17     DOI: http://dx.doi.org/10.4143/crt.2021.978
      
6 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee
Cancer Res Treat.2022;54(3):827-833.   Published online 2021 October 13     DOI: http://dx.doi.org/10.4143/crt.2021.791
      
7 임상검체에서 BRCA 돌연변이를 검출하는 차세대염기서열분석법의 임상적 효용성 평가
Man Jin Kim, Byeong Ju Song, Si Eun Kim, Chang Seon Lee, Ji-Eun Im, Ensel Oh, Keunsook Lee, Sung Im Cho, Kwang Joong Kim, Sung Sup Park, Moon-Woo Seong
Lab Med Online.2021;11(4):283-289.   Published online 2021 October 1     DOI: http://dx.doi.org/10.47429/lmo.2021.11.4.283
      
8 Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Young Min Hur, Jaehee Mun, Mi-Kyung Kim, Maria Lee, Yun Hwan Kim, Seung-Cheol Kim
J Korean Med Sci.2021;36(38):e241.  Published online 2021 August 17     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e241
      
9 Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
Boyoung Park, Dongwon Kim, Jiyoung Kim, Bom Yi Lee, Junghyun Yoon, Sung-Won Kim
Cancer Res Treat.2022;54(2):375-382.   Published online 2021 August 9     DOI: http://dx.doi.org/10.4143/crt.2021.449
      
10 Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations
Kyung Hwan Kim, Han Sang Kim, Seung-seob Kim, Hyo Sup Shim, Andrew Jihoon Yang, Jason Joon Bock Lee, Hong In Yoon, Joong Bae Ahn, Jee Suk Chang
Cancer Res Treat.2022;54(1):54-64.   Published online 2021 June 4     DOI: http://dx.doi.org/10.4143/crt.2020.1247
      
11 Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation
Go Woon Jeong, Wonkyo Shin, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim
Cancer Res Treat.2021;53(1):207-211.   Published online 2020 August 11     DOI: http://dx.doi.org/10.4143/crt.2020.364
      
12 Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.2020;52(4):1229-1241.   Published online 2020 July 27     DOI: http://dx.doi.org/10.4143/crt.2020.557
      
13 Clinicopathological characteristics of BRCA-associated breast cancer in Asian patients
Eun-Kyu Kim, So Yeon Park, Sung-Won Kim
J Pathol Transl Med.2020;54(4):265-275.   Published online 2020 May 14     DOI: http://dx.doi.org/10.4132/jptm.2020.04.07
      
14 BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
Anbok Lee, Byung-In Moon, Tae Hyun Kim
Ann Lab Med.2020;40(2):114-121.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.114
      
15 Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
Jaeeun Yoo, Gun Dong Lee, Jee Hae Kim, Seung Nam Lee, Hyojin Chae, Eunhee Han, Yonggoo Kim, Myungshin Kim
Ann Lab Med.2020;40(2):148-154.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.148
      
16 Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
Obstet Gynecol Sci.2019;62(6):411-419.   Published online 2019 October 11     DOI: http://dx.doi.org/10.5468/ogs.2019.62.6.411
      
17 Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer
Kyung-Hwak Yoon, Sumin Chae, Eunyoung Kang, Hee-Chul Shin, Jee Hyun Kim, In Ah Kim, So Yeon Park, Sung-Won Kim, Eun-Kyu Kim
J Breast Cancer.2019;22(4):587-598.   Published online 2019 September 30     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e47
      
18 Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
Chyong-Huey Lai, Elizabeth Vallikad, Hao Lin, Lan-Yan Yang, Shih-Ming Jung, Hsueh-Erh Liu, Yu-Che Ou, Hung-Hsueh Chou, Cheng-Tao Lin, Huei-Jean Huang, Kuan-Gen Huang, Jiantai Qiu, Yao-Ching Hung, Tzu-I Wu, Wei-Yang Chang, Kien-Thiam Tan, Chiao-Yun Lin, Angel Chao, Chee-Jen Chang
J Gynecol Oncol.2020;31(1):e5.  Published online 2019 July 26     DOI: http://dx.doi.org/10.3802/jgo.2020.31.e5
      
19 Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis
Ernesto Barzola Navarro, Emilio Vicente López, Yolanda Quijano, Riccardo Caruso, Valentina Ferri, Hipolito Durand, Isabel Fabra Cabrera, Eduardo Diaz Reques, Benedetto Ielpo, Anastasiia Yuriyivna Glagolieva, Carlos Plaza
Ann Hepatobiliary Pancreat Surg.2019;23(2):200-205.   Published online 2019 May 31     DOI: http://dx.doi.org/10.14701/ahbps.2019.23.2.200
      
20 Checkpoint-inhibition in ovarian cancer: rising star or just a dream?
Klaus Pietzner, Sara Nasser, Sara Alavi, Silvia Darb-Esfahani, Mona Passler, Mustafa Zelal Muallem, Jalid Sehouli
J Gynecol Oncol.2018;29(6):e93.  Published online 2018 August 13     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e93
      

 1 of 3